
要約 目的: To analyze the status and number of metabolic and bariatric surgery (MBS) in China in 2023. 方法: Based on the Chinese Obesity and Metabolic Surgery Database (COMES Database), we analyzed and estimated the types and numbers of MBS and the mortality rate between January 1 and December 31 in 2023, and the numbers of bariatric s
要約 目的: 2023 年の中国における代謝・肥満手術 (MBS) の状況と件数を分析する。 方法: Based on the Chinese Obesity and Metabolic Surgery Database (COMES Database), we analyzed and estimated the types and numbers of MBS and the mortality rate between January 1 and December 31 in 2023, and the numbers of bariatric surgeons and case managers of each hospital. この研究 did not include data from the Hong Kong SAR, Macao SAR, and Taiwan region of China. 結果 : 420 hospitals were included in this study, covering 31 provinces (autonomous regions and municipalities) and 173 cities, with a total 推定37 249件。 It was also estimated that there were 850 hospitals in the country, with 1250 bariatric surgeons and 600 case managers MBSに携わる。 最も多く実施された MBS の上位 3 つは、スリーブ状胃切除術 (SG、30,352 例、81.5%)、一吻合胃バイパス術 (OAGB、 1,228 件、3.3%)、 Roux-en-Y 胃バイパス術 (RYGB、901 件、2.4%)。ナイン (0.02%) deaths were reported. 結論: MBS の数は 2023 年も増加し続けます。最も多く行われた手術は SG、OAGB、RYGB でした。 It is important to pay attention さまざまな手術の傾向を把握し、センター間の臨床および研究の連携を強化し、標準化と品質を促進します。 改善 MBSの。 We should focus on the obesity-related humanities, patient education, policy implementation, and international collaborations. これにより、世界的にMBSにおける当社の影響力と競争力が強化され、肥満のパンデミックに対処するための準備が整います。